Skip to main content
. 2021 Oct 1;36(44):e278. doi: 10.3346/jkms.2021.36.e278

Table 2. Comparison between the EIM-positive and -negative groups in CD patients.

Variables EIM-positive group (n = 34) EIM-negative group (n = 103) P
Male sex 21 (61.8) 77 (74.8) 0.216
Age at diagnosis, yr 13.9 (11.7–16.3) 14.1 (12.6–15.1) 0.929
Age at maximum follow-up, yr 17.8 (15.1–20.3) 18.0 (15.6–20.3) 0.325
Paris classification age 0.092
A1a 7 (6.8) 6 (17.6)
A1b 89 (86.4) 24 (70.6)
A2 7 (6.8) 4 (11.8)
Lower GI tract location 0.523
L1 12 (11.7) 2 (5.9)
L2 6 (5.8) 3 (8.8)
L3 85 (82.5) 29 (85.3)
Upper GI tract location 0.407
No involvement 40 (38.8) 11 (29.4)
L4a 20 (19.4) 10 (29.4)
L4b 18 (17.5) 8 (23.5)
L4a+b 25 (24.3) 7 (20.6)
GI tract behavior 0.814
B1 87 (84.5) 27 (79.4)
B2 13 (12.6) 6 (17.6)
B3/B2B3 3 (2.9) 1 (2.9)
Perianal modifiers 43 (41.7) 18 (52.9) 0.347
Growth retardation 20 (19.4) 12 (35.5) 0.125
PCDAI at diagnosis 42.5 (17.5–50) 42.5 (35.0–47.5) 0.547
CRP at diagnosis, mg/dL 3.8 (1.9–6.6) 3.2 (0.3–6.3) 0.186
ESR at diagnosis, mm/hr 44 (28–65) 39.5 (20–74) 0.405
FC at diagnosis, mg/kg 526 (248–1,000) 350 (66–684) 0.131

Data are expressed as median (interquartile range) for continuous variables that did not show normal distribution, unless otherwise indicated.

EIM = extraintestinal manifestation, CD = Crohn's disease, GI = gastrointestinal, A1a = 0–9 years, A1b = 10–16 years, A2 = ≤ 17 years, L1 = distal 1/3 ileum ± limited cecal disease, L2 = colonic disease, L3 = ileocolonic disease, L4a = upper disease proximal to ligament of Treitz, L4b = upper disease distal to the ligament of Treitz and proximal to the distal 1/3 ileum, L4ab = upper disease involvement in both L4a and L4b, B1 = nonstricturing nonpenetrating behavior, B2 = stricturing behavior, B3 = penetrating behavior, B2B3 = both B2 and B3, PCDAI = Pediatric Crohn's Disease Activity Index, CRP = C-reactive protein, ESR = erythrocyte sedimentation rate, FC = fecal calprotectin.